Calcico Therapeutics is Biotechnology in United Kingdom that focus on CRAC channel business. Founded in 2012. They cover business area such as operator, selective small molecule, atopic dermatitis, calcium-release activate channel inhibitor, selective CRAC channel screening, molecule characterization, medical professional, inflammatory, autoimmune condition.
2012
( 12 years old in 2024 )
CRAC Channel
-
2nd Floor, 158-160 North Gower Street
London NW1 2ND
England, United Kingdom
Private
operatorselective small moleculeatopic dermatitiscalcium-release activate channel inhibitorselective CRAC channel screeningmolecule characterizationmedical professionalinflammatoryautoimmune condition
* We use standard office opening hours in near Calcico Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Calcico Therapeutics is Biotechnology business from United Kingdom that founded in 2012 (12 years old in 2024), Calcico Therapeutics business is focusing on CRAC Channel.
Calcico Therapeutics headquarter office and corporate office address is located in 2nd Floor, 158-160 North Gower Street London NW1 2ND England, United Kingdom.
Calcico Therapeutics was founded in United Kingdom.
In 2024, Calcico Therapeutics is currently focus on CRAC channel sector.
Above is snippet of Google Trends for "CRAC channel" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Calcico Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
